| Groups |  |  |  | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental | Waitlist Control | |||||||||
Stage-I | Stage-II | Stage-I | Stage-II | |||||||
Baseline M (SD) | Post-Test M (SD) | Baseline M (SD) | Post-Test M (SD) | Baseline M (SD) | Post-Test M (SD) | Baseline M (SD) | Post-Test M (SD) | F | ηp2 | |
DEPS | 23.29 (3.87) | 5.00 (2.91) | 19.25 (4.10) | 6.25 (2.29) | 18.98 (5.24) | 18.40 (6.95) | 16.93 (5.22) | 17.74 (7.23) | 39.55*** | .679 |
ANXS | 21.72 (5.61) | 5.07 (2.97) | 20.75 (6.06) | 4.93 (2.91) | 15.87 (5.36) | 16.67 (6.00) | 14.34 (6.44) | 15.34 (6.16) | 73.32*** | .797 |
STSS | 29.21 (4.12) | 6.86 (2.18) | 22.32 (6.11) | 8.50 (2.25) | 21.13 (6.36) | 22.20 (6.76) | 22.14 (6.20) | 22.47 (6.17) | 119.77*** | .865 |
DAS | 11.85 (1.61) | 3.14 (0.87) | 11.06 (4.24) | 4.38 (1.93) | 11.00 (2.83) | 9.67 (2.36) | 9.74 (3.22) | 9.34 (2.56) | 22.71*** | .549 |
SWLS | 12.36 (2.93) | 22.15 (3.66) | 14.40 (2.64) | 24.06 (5.63) | 13.47 (3.14) | 13.93 (2.66) | 13.60 (2.83) | 14.20 (3.43) | 22.05*** | .542 |
RSES | 13.57 (3.44) | 20.00 (2.26) | 15.63 (3.85) | 22.13 (1.86) | 15.40 (2.83) | 15.07 (2.83) | 16.87 (5.72) | 17.27 (4.84) | 36.19*** | .660 |